Cleanaway Waste Management Limited (ASX:CWY – Get Free Report) insider Philippe Etienne acquired 28,089 shares of the business’s stock in a transaction on Monday, February 19th. The stock was acquired at an average price of A$2.67 ($1.74) per share, with a total value of A$74,857.19 ($48,926.26). Cleanaway Waste Management Price Performance The company has a […]
GSK PLC on Friday reported positive preliminary results from a phase 3 trial regarding its 5-in-1 meningococcal ABCWY vaccine candidate.
Subjects in the trial were healthy individuals aged between 10. | May 12, 2023
GSK presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains
. | May 12, 2023
Adult with meningococcal disease
PLEASE NOTE: TO RESPECT THE PRIVACY OF PATIENTS, NO FURTHER INDENTIFYING INFORMATION WILL BE PROVIDED, INCLUDING AGE, GENDER AND LOCATION.
The Department of Health today reported that an adult has been diagnosed with meningococcal serogroup Y disease and is currently recovering in hospital.
Meningococcal disease is an uncommon, life-threatening illness caused by a bacterial infection of the blood and/or the membranes that line the spinal cord and brain, and occasionally of other sites, such as the throat, lungs or large joints.
To date in 2021, six meningococcal cases have been reported in WA; three were serogroup B, one was serogroup Y, and two were cases where the type could not be determined. In 2020, 11 meningococcal cases were reported in WA, including one death.